Therefore, disruption of the balance between HIF-1α and HIF-2α by extracellular assaults may lead to HIF-2α-mediated oncogenic activation of target genes, contributing to cancer cell survival in stringent tumor microenvironments [18, 19]. The gene discussed is EPAS1; the disease is cancer.